Valeant Pharmaceuticals

Manufacturing Supervisor (2nd Shift)

US-MO-St. Louis
Job ID
8531
Category
Operations
Pos. Type
Full Time

Overview

Supervise production personnel in manufacture and packaging single use, medical device products. 

Hours: 2nd shift, 3:45-2:15, Mon-Thursday, Friday’s as needed for overtime. 

Responsibilities

  • Ensure production is in compliance with established quality standards and manufacturing SOPs.
  • Manage production flow and effective utilizations of equipment, material, and labor resources.
  • Interface with Planning to understand production schedule and meet production requirements in a timely manner.
  • Work with QA and Engineering to resolve production quality issues.
  • Monitor and report area safety and housekeeping.
  • Help hire and train employees.
  • Resolved and/or report employee issues.
  • Monitor employee attendance and performance.
  • Work with HR and Senior management to carry out discipline actions.
  • Develop and support continuous improvement.

Qualifications

Required Education:

 

B.A./B. S Engineering or related field.

 

Required Skills/Qualifications:

Interpersonal, organizational, and motivational skills; strong analytical skill; Proficient in MS Office Applications – Excel, Word, PowerPoint, Outlook. 

 

Preferred Skills/Qualifications:

Supervisory training preferred. Lean and Six Sigma (Greenbelt/Blackbelt) training a plus. Knowledge and aptitude in environmentally controlled rooms, bioburden control, clean rooms a plus.

 

Required Experience:

Two or more years of directly related production experience in high mix, low volume medical device manufacturing environment. Minimum 2 years of manufacturing supervisory experience in GMP environment, specifically assembly and packaging of medical devices in environmentally controlled areas. Clear understanding of GMPs and FDA regulatory guidelines

 

Preferred Experience:

 

Experience in supervising a culturally diverse work team is a plus.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed